Home › Multiple Sclerosis › District of Columbia › Washington
Multiple Sclerosis clinical trials in Washington, DC
13 studies for Multiple Sclerosis are looking for participants at sites in and around Washington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)
RecruitingPhase 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System
RecruitingObservational studyHealthy volunteers welcome
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RecruitingPhase 1
- MedStar Georgetown University Hospital, Washington D.C.
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 mi away
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
RecruitingObservational study
- TG Therapeutics Investigational Trial Site, Washington D.C.
Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis Plaques
RecruitingPhase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)
RecruitingObservational studyHealthy volunteers welcome
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Natural History Study of Progressive Multifocal Leukoencephalopathy (PML)
RecruitingObservational studyHealthy volunteers welcome
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
An Open-label Study of AZD0120 in Adults With Multiple Sclerosis
RecruitingPhase 1
- Research Site, Washington D.C.
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
RecruitingPhase 3
- Georgetown University Hospital, Washington D.C.
- Medstar Washington Hosp Ctr, Washington D.C.
- Mid Atlantic Epilepsy and Sleep Ctr, Bethesda · 7 mi away
Pathological Basis of MRI Signal Changes in Multiple Sclerosis
RecruitingObservational studyHealthy volunteers welcome
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Central Nervous System Uptake of Anti-CD8+ T Cell Minibodies in Multiple Sclerosis and Progressive Multifocal Leukoencephalopathy
RecruitingPhase 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Genes and Environment in Multiple Sclerosis
RecruitingObservational studyHealthy volunteers welcome
- National Institute of Neurological Disorders and Stroke, Bethesda · 7 mi away
A Study on the Safety of Ozanimod Exposure in Pregnant Women and Their Offspring
RecruitingObservational study
- Evidera INC., Bethesda · 7 mi away
- Evidera, Bethesda · 7 mi away
About Multiple Sclerosis
Multiple sclerosis (MS) slows down or blocks messages between the brain and body. MS can be mild or severe. Learn about MS symptoms and treatment.
More about Multiple Sclerosis on MedlinePlus
Multiple Sclerosis trials in other cities
- New York City, NY17 studies
- Chicago, IL15 studies
- Boston, MA14 studies
- Cleveland, OH9 studies
- St. Louis, MO8 studies
- Kansas City, KS8 studies
- Birmingham, AL8 studies
- San Francisco, CA8 studies
- Columbus, OH7 studies
- Aurora, CO7 studies
- Baltimore, MD7 studies
- Farmington Hills, MI6 studies
Other studies in Washington
- Cancer (all types)58 studies
- Non-Small Cell Lung Cancer55 studies
- Breast Cancer46 studies
- Metastatic Cancer43 studies
- Lung Cancer41 studies
- Prostate Cancer38 studies
- Obesity33 studies
- Colorectal Cancer29 studies
- Cardiovascular Disease29 studies
- Bladder Cancer26 studies
- Acute Myeloid Leukemia24 studies
- Lymphoma23 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.